Article By:
Terry Chrisomalis
Monday, October 5, 2015 6:54 PM EDT
Shares of Spark Therapeutics ended the day up 25% after reporting positive phase 3 results for its SPK-RPE65 gene therapy.
Monday Morning Pre-Market Insights: CLDX, CLDN, CTIC, TGTX
Wow! $CLDN gives me goose bumps! I'm very bullish.